Search

Your search keyword '"de Vos-Geelen, Judith"' showing total 320 results

Search Constraints

Start Over You searched for: Author "de Vos-Geelen, Judith" Remove constraint Author: "de Vos-Geelen, Judith"
320 results on '"de Vos-Geelen, Judith"'

Search Results

1. Prebiotic fibre mixtures counteract the manifestation of gut microbial dysbiosis induced by the chemotherapeutic 5-Fluorouracil (5-FU) in a validated in vitro model of the colon

2. Longitudinal associations of diurnal rest-activity rhythms with fatigue, insomnia, and health-related quality of life in survivors of colorectal cancer up to 5 years post-treatment

4. Tackling challenges in rare diseases: The ISGACA approach on non-pancreatic cancers in the periampullary region

6. Preoperative chemoradiotherapy but not chemotherapy is associated with reduced risk of postoperative pancreatic fistula after pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a nationwide analysis

10. Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

11. Population-based impact of COVID-19 on incidence, treatment, and survival of patients with pancreatic cancer

12. Practice variation in venous resection during pancreatoduodenectomy for pancreatic cancer: A nationwide cohort study

14. Prebiotic fibre mixtures counteract the manifestation of gut microbial dysbiosis induced by the chemotherapeutic 5-Fluorouracil (5-FU) in a validated in vitro model of the colon

17. Treatment and overall survival of four types of non-metastatic periampullary cancer: nationwide population-based cohort study

20. Quality of Life and Survival of Metastatic Colorectal Cancer Patients Treated With Trifluridine-Tipiracil (QUALITAS)

23. Diagnostic accuracy of cross-sectional and endoscopic imaging in ampullary tumours: systematic review

24. A population-based study on incidence, treatment, and survival in ampullary cancer in the Netherlands

25. Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicenter prospective cohort

27. Nationwide compliance with a multidisciplinary guideline on pancreatic cancer during 6-year follow-up

28. Nerve fibers in the tumor microenvironment in neurotropic cancer—pancreatic cancer and cholangiocarcinoma

29. Cellular Components Contributing to the Development of Venous Thrombosis in Patients with Pancreatic Cancer.

30. Surgical Complications in a Multicenter Randomized Trial Comparing Preoperative Chemoradiotherapy and Immediate Surgery in Patients With Resectable and Borderline Resectable Pancreatic Cancer (PREOPANC Trial)

31. Impact of nationwide implementation of best practices in pancreatic cancer care (PACAP-1): a stepped-wedge cluster randomised controlled trial

32. Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

38. Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands: A Stepped-Wedge Randomized Clinical Trial

40. Transarterial Chemoembolization With Drug-Eluting Beads Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Outcomes From a Multicenter, Randomized, Phase 2 Trial (the TRENDY Trial)

41. Surgical Complications in a Multicenter Randomized Trial Comparing Preoperative Chemoradiotherapy and Immediate Surgery in Patients With Resectable and Borderline Resectable Pancreatic Cancer (PREOPANC Trial)

44. Outcomes, treatment and risk factors of portomesenteric venous thrombosis following venous resection during pancreatoduodenectomy for pancreatic cancer: A multicenter retrospective analysis

45. Impact of network treatment in patients with resected pancreatic cancer on use and timing of chemotherapy and survival

46. Population-based impact of COVID-19 on incidence, treatment, and survival of patients with pancreatic cancer

48. Timing of start of systemic treatment in patients with asymptomatic metastasized pancreatic cancer (TIMEPAN): a protocol of a multicenter prospective patient preference non-randomized trial.

49. Adjuvant and first-line palliative chemotherapy regimens in patients diagnosed with periampullary cancer

50. Pharmacokinetic Interaction Between the MEK1/MEK2 Inhibitor Trametinib and Oral Contraceptives Containing Norethindrone and Ethinyl Estradiol in Female Patients With Solid Tumors

Catalog

Books, media, physical & digital resources